ConductScience.org, home

Paper36950503

The application of corticosteroids for pathological scar prevention and treatment: current review and update.

Sheng M and 4 others. Burns Trauma, 2023. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. The application of corticosteroids for pathological scar prevention and treatment: current review and update. Papers, record 36950503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36950503

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The application of corticosteroids for pathological scar prevention and treatment: current review and update.
PubMed
Journal
Burns Trauma
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
8.49
iCite
Revised in PubMed
2023-03-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sheng MMeiying
2Chen YYunsheng
3Li HHua
4Zhang YYixin
5Zhang ZZhenghttps://orcid.org/0000-0003-1961-7070

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References80

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124490743Lasers as an approach for promoting drug delivery via skin.Expert Opin Drug Deliv2014https://conductscience.org/library/papers/24490743PubMed
230151017Role of betamethasone valerate 2.250 mg medicated plaster in the treatment of psoriasis and other dermatological pathologies: a review.Drugs Context2018https://conductscience.org/library/papers/30151017PubMed
37679551Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts.Am J Pathol1993https://conductscience.org/library/papers/7679551PubMed
434361084Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier.Int J Mol Sci2021https://conductscience.org/library/papers/34361084PubMed
536169040Overcoming skin barriers through advanced transdermal drug delivery approaches.J Control Release2022https://conductscience.org/library/papers/36169040PubMed
622954589Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.FASEB J2012https://conductscience.org/library/papers/22954589PubMed
733719380Topical Corticosteroids: Choice and Application.Am Fam Physician2021https://conductscience.org/library/papers/33719380PubMed
834785356Trilayer microneedle array assisted transdermal and intradermal delivery of dexamethasone.Int J Pharm2022https://conductscience.org/library/papers/34785356PubMed
922272655A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision.Dermatol Surg2012https://conductscience.org/library/papers/22272655PubMed
1012920152The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression.Endocr Rev2003https://conductscience.org/library/papers/12920152PubMed
113470308Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.J Clin Invest1987https://conductscience.org/library/papers/3470308PubMed
1225068544Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment.Dermatol Surg2014https://conductscience.org/library/papers/25068544PubMed
1318997767Transdermal drug delivery.Nat Biotechnol2008https://conductscience.org/library/papers/18997767PubMed
1432910934Insights into glucocorticoid responses derived from omics studies.Pharmacol Ther2021https://conductscience.org/library/papers/32910934PubMed
1510513931On the nature of hypertrophic scars and keloids: a review.Plast Reconstr Surg1999https://conductscience.org/library/papers/10513931PubMed
1625006550Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery.Int J Pharm Investig2014https://conductscience.org/library/papers/25006550PubMed
1711386039Topical steroids--a new approach after 50 years.Med Sci Monit2001https://conductscience.org/library/papers/11386039PubMed
1811817968New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use.Am J Clin Dermatol2002https://conductscience.org/library/papers/11817968PubMed
1912174062Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts.Dermatol Surg2002https://conductscience.org/library/papers/12174062PubMed
2021735339Clinical characteristics of facial keloids treated with surgical excision followed by intra- and postoperative intralesional steroid injections.Aesthetic Plast Surg2012https://conductscience.org/library/papers/21735339PubMed

See all 80 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42973896Management of Axillary Burn Sequelae: Prevention, Surgical Treatment and Functional Outcomes.Ann Burns Fire Disasters2026https://conductscience.org/library/papers/42973896PubMed
42825928Treatment of hypertrophic scars using fractional CO2 laser alone in comparison with adding botulinium toxin either intalesional injection or assisted drug delivery.Lasers Med Sci2026https://conductscience.org/library/papers/42825928PubMed
42780693Current therapeutic strategies and available research models for investigating hypertrophic scars.Front Pharmacol2026https://conductscience.org/library/papers/42780693PubMed
42657113Hydrogel microneedles functioning in pathological surroundings: where soft materials overcome hard scars.Mater Today Bio2026https://conductscience.org/library/papers/42657113PubMed
42621324Targeting macrophage function with botulinum toxin: a novel translational strategy for preventing and treating pathological scars.Postepy Dermatol Alergol2026https://conductscience.org/library/papers/42621324PubMed
42461415Combined compound betamethasone and 595 nm pulsed dye laser improves hypertrophic scar and is associated with enhanced autophagy in myofibroblasts.Lasers Med Sci2026https://conductscience.org/library/papers/42461415PubMed
42321277A combinatorial therapeutic platform based on graphene-collagen cryogel and apoptotic vesicles for modulating hypertrophic scars.Sci Rep2026https://conductscience.org/library/papers/42321277PubMed
42260901Resveratrol Ameliorates Hypertrophic Scar Formation by Regulating ASIC3-Mediated Fibroblast-Macrophage Crosstalk: A Mechanistic Study.Phytother Res2026https://conductscience.org/library/papers/42260901PubMed
42253930Preclinical Efficacy and Safety Study of a Novel Dermal Fibroblast Modulating Drug, SLI-F06, in Cutaneous Wound Healing.MedComm (2020)2026https://conductscience.org/library/papers/42253930PubMed
42108543Clinical Efficacy of Local Injection of Compound Betamethasone Versus Triamcinolone Acetonide in the Treatment of Hypertrophic Scars: A Retrospective Analysis of 126 Patients.J Cosmet Dermatol2026https://conductscience.org/library/papers/42108543PubMed
41810075Scar Inhibition in Wound Healing: Mechanisms, Design, and Recent Advances.Exploration (Beijing)2026https://conductscience.org/library/papers/41810075PubMed
41754891Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars.Pharmaceutics2026https://conductscience.org/library/papers/41754891PubMed
41707648Chemomechanical remodeling of glucocorticoid-sensitive fibroblasts for multimodal synergistic therapy of skin fibrosis.Cell Rep Med2026https://conductscience.org/library/papers/41707648PubMed
41675148Application of IFN-γ-Licensed urine-derived stem cells in SIS hydrogel promotes scar-free wound healing by immunomodulation and microenvironment remodeling.Bioact Mater2026https://conductscience.org/library/papers/41675148PubMed
41596464Transient Receptor Potential (TRP) Channels as Fundamental Regulators of Fibrosis and Pruritus-A New Therapeutic Target for Pathological Scar Management.Int J Mol Sci2026https://conductscience.org/library/papers/41596464PubMed
41216187Single cell deciphering of pruritic keloids: the interaction between fibroblasts and Schwann cells through the Midkine signaling.Burns Trauma2025https://conductscience.org/library/papers/41216187PubMed
41193897
Therapeutic Effect of Topical Triamcinolone Acetonide Combined With 10600-nm Ablative Fractional Carbon Dioxide Laser or 1565-nm Non-Ablative Fractional Laser on Hypertrophic Scars in the Rabbit Ear Model.
Aesthetic Plast Surg2026https://conductscience.org/library/papers/41193897PubMed
40918477Effects of combined treatment with Curcuma longa extract, curcumin, or bisdemethoxycurcumin and UVA on imiquimod-induced psoriasis-like lesions in BALB/c mice.Food Sci Biotechnol2025https://conductscience.org/library/papers/40918477PubMed
40852404Clinical guidance paper VVOG-CRGOLFB prevention and management of obstetrical perineal trauma.Eur J Obstet Gynecol Reprod Biol X2025https://conductscience.org/library/papers/40852404PubMed
40703263Photobiomodulation therapy in keloid management: a comprehensive review.Front Med (Lausanne)2025https://conductscience.org/library/papers/40703263PubMed

See all 35 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36950503

GET https://conductscience.org/api/papers/v1/36950503/references?page=2